(19)
(11) EP 2 707 713 A2

(12)

(88) Date of publication A3:
28.03.2013

(43) Date of publication:
19.03.2014 Bulletin 2014/12

(21) Application number: 12738594.6

(22) Date of filing: 10.05.2012
(51) International Patent Classification (IPC): 
G01N 33/50(2006.01)
C07K 14/605(2006.01)
(86) International application number:
PCT/IB2012/001090
(87) International publication number:
WO 2012/153196 (15.11.2012 Gazette 2012/46)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 10.05.2011 US 201161484422 P

(71) Applicant: Zealand Pharma A/S
2600 Glostrup (DK)

(72) Inventors:
  • JUST, Rasmus
    DK-2200 Copenhagen (DK)
  • LOECHEL, Steven, Charles
    DK-2000 Frederiksberg (DK)
  • ØSTERLUND, Torben
    S-224 72 Lund (SE)
  • RIBER, Ditte
    DK-2700 Brønshøj (DK)
  • FOSGERAU, Keld
    DK-2720 Vanløse (DK)

(74) Representative: Forrest, Graham Robert et al
Mewburn Ellis LLP 33 Gutter Lane
London EC2V 8AS
London EC2V 8AS (GB)

   


(54) GLU-GLP-1 DUAL AGONIST SIGNALING-SELECTIVE COMPOUNDS